Chase AIPricingFAQs
Display currency
Loading news…

Variant Pharmaceuticals

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
Weston, Florida, United States Founded 2014 1-10 employees For Profit

Variant Pharmaceuticals is a specialty pharmaceutical company utilizing proprietary technologies to create and develop.

Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
0
Monthly Visits
Available in Pro
Contacts
265
Patents
1

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private
Valuation range
$10M to $50M

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
2
Active products
4
Patents granted
1
Trademarks
0
Top patent class
Medical Or Veterinary Science; Hygiene

Company Info

Founded
2014
Employees
1-10
Operating status
Active
Company type
For Profit
Org types
company
Founders
2
News articles
3
HQ
Weston, Florida, United States
Region
Greater Miami Area, East Coast, Southern US

Signals & Scores

Heat score
Low
Growth score
Low
Trend (7d)
0.2
Trend (30d)
-0.1
Trend (90d)
-0.7
265
professional contacts at Variant Pharmaceuticals
Contact execs at Variant Pharmaceuticals

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to Variant Pharmaceuticals

Loading news…

FAQs about Variant Pharmaceuticals

People who checked this page also checked these

Browse the full Acquirezy directory.
Variant Pharmaceuticals - Company Profile, Full Acquisitions List, Funding and Investments